Department of Surgery, University of Michigan, Ann Arbor, MI 48109, USA.
Rogel Cancer Center, University of Michigan, 1500 E. Medical Center Drive, 6219 Cancer Center Ann Arbor, Ann Arbor, MI 48109, USA.
Curr Oncol. 2023 May 24;30(6):5240-5250. doi: 10.3390/curroncol30060398.
Retroperitoneal sarcomas are extremely rare, comprising <15% of primary sarcomas. Distant metastasis occurs in about 20% of cases, with pulmonary and hepatic metastasis as the most common sites of hematogenous spread. Although surgical resection is well established as the main treatment of localized primary disease, there are limited guidelines for the surgical treatment of intra-abdominal and distant metastases. There are inadequate systemic treatment options for patients with metastatic sarcoma, thereby necessitating the consideration of surgical options in carefully selected patients. Key points to consider include tumor biology, patient fitness and co-morbidities, overall prognosis, and goals of care. Multidisciplinary sarcoma tumor board discussion for each case is an essential practice in order to deliver the best care to these patients. The purpose of this review is to summarize the published literature on the past and present role of surgery in the treatment of oligometastatic retroperitoneal sarcoma in order to inform the management of this difficult disease.
腹膜后肉瘤极为罕见,占原发性肉瘤的<15%。约 20%的病例发生远处转移,肺和肝转移是血行播散最常见的部位。尽管手术切除已被确立为局限性原发性疾病的主要治疗方法,但对于腹腔内和远处转移的手术治疗仍缺乏指南。转移性肉瘤患者的系统治疗选择有限,因此需要在精心挑选的患者中考虑手术选择。需要考虑的关键要点包括肿瘤生物学、患者的健康状况和合并症、总体预后以及治疗目标。对每个病例进行多学科肉瘤肿瘤委员会讨论是为这些患者提供最佳护理的必要实践。本综述的目的是总结已发表的文献,以了解手术在治疗寡转移性腹膜后肉瘤中的过去和现在的作用,从而为这种治疗困难的疾病提供信息。